Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other financing activities (2020 - 2024)

Fennec Pharmaceuticals filings provide 4 years of Other financing activities readings, the most recent being $1.7 million for Q1 2024.

  • On a quarterly basis, Other financing activities changed N/A to $1.7 million in Q1 2024 year-over-year; TTM through Dec 2024 was $1.7 million, a N/A change, with the full-year FY2024 number at $1.7 million, up 57900.0% from a year prior.
  • Other financing activities hit $1.7 million in Q1 2024 for Fennec Pharmaceuticals, up from $224000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.7 million in Q1 2024 to a low of $23000.0 in Q2 2020.
  • Median Other financing activities over the past 4 years was $117000.0 (2020), compared with a mean of $429200.0.
  • The widest YoY moves for Other financing activities: up 82.61% in 2021, down 82.61% in 2021.
  • Fennec Pharmaceuticals' Other financing activities stood at $117000.0 in 2020, then plummeted by 64.1% to $42000.0 in 2021, then surged by 433.33% to $224000.0 in 2022, then soared by 676.79% to $1.7 million in 2024.
  • The last three reported values for Other financing activities were $1.7 million (Q1 2024), $224000.0 (Q4 2022), and $42000.0 (Q2 2021) per Business Quant data.